Overview

Zollinger-Ellison Syndrome (ZES) is a rare condition where one or more tumors form in the pancreas or the upper part of the small intestine (duodenum). These tumors, called gastrinomas, secrete large amounts of the hormone gastrin, which causes the stomach to produce too much acid. This leads to severe peptic ulcers and other digestive problems. When ZES occurs with hypercalcemia (high levels of calcium in the blood), it presents additional challenges and symptoms.

ZES with hypercalcemia is extremely rare, affecting fewer than 1 in 1 million people annually. It most commonly occurs in adults between the ages of 30 and 60, though it can affect people of any age. About 25-30% of gastrinomas are associated with a genetic condition called Multiple Endocrine Neoplasia type 1 (MEN1), which also increases the risk of hypercalcemia due to parathyroid tumors.

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), ZES accounts for less than 1% of all peptic ulcer cases. However, recognizing it is crucial because it requires different treatment than typical ulcers.

Symptoms

The symptoms of Zollinger-Ellison Syndrome with hypercalcemia can vary widely but often include a combination of digestive issues and symptoms related to high calcium levels. Below is a detailed list of potential symptoms:

Digestive Symptoms (from ZES)

• Severe abdominal pain: Often described as burning or gnawing, typically in the upper abdomen. This pain may not respond to typical ulcer medications like antacids.
• Diarrhea: Frequent, watery stools, which can lead to dehydration and weight loss. This occurs in up to 75% of people with ZES.
• Heartburn or acid reflux: A burning sensation in the chest or throat due to excess stomach acid.
• Nausea and vomiting: Sometimes with blood if ulcers are bleeding.
• Bleeding in the digestive tract: This can cause vomiting blood (hematemesis) or black, tarry stools (melena).
• Unintentional weight loss: Due to poor nutrient absorption and chronic diarrhea.
• Loss of appetite: Often accompanied by a feeling of fullness.

Symptoms of Hypercalcemia

Hypercalcemia occurs when calcium levels in the blood are too high, often due to overactive parathyroid glands (common in MEN1) or other underlying conditions. Symptoms may include:

• Fatigue and weakness: Feeling unusually tired or weak, even after rest.
• Excessive thirst and frequent urination: High calcium levels can affect kidney function, leading to increased urine production.
• Bone pain: Hypercalcemia can weaken bones, causing pain or increasing the risk of fractures.
• Kidney stones: High calcium levels can lead to the formation of painful kidney stones.
• Muscle aches and cramps: Particularly in the arms, legs, or abdomen.
• Constipation: High calcium can slow down digestive motility.
• Confusion or memory problems: Severe hypercalcemia can affect brain function, leading to difficulty concentrating, memory loss, or even depression.
• Irregular heartbeat: High calcium can interfere with the electrical signals that regulate the heart.

In some cases, people with ZES and hypercalcemia may also experience symptoms related to MEN1, such as:

• Hormonal imbalances (e.g., from pituitary or adrenal tumors).
• Skin rashes or lipomas (fatty tumors under the skin).

If you experience any of these symptoms, especially if they are persistent or severe, consult a healthcare provider for evaluation.

Causes and Risk Factors

Causes

Zollinger-Ellison Syndrome is caused by gastrinomas, which are tumors that secrete excessive amounts of gastrin. These tumors are usually found in the pancreas or duodenum but can also occur in other parts of the digestive tract or nearby lymph nodes. In about 25-30% of cases, ZES is associated with MEN1, a genetic disorder that causes tumors in multiple endocrine glands, including the parathyroid glands (which can lead to hypercalcemia).

Hypercalcemia in ZES is often due to:

• Primary hyperparathyroidism: Overactive parathyroid glands (common in MEN1) produce too much parathyroid hormone (PTH), which increases calcium levels in the blood.
• Bone metastasis: In rare cases, gastrinomas can spread to the bones, releasing calcium into the bloodstream.
• Other causes: Such as vitamin D toxicity, certain medications (e.g., lithium), or other cancers.

Risk Factors

While ZES with hypercalcemia is rare, certain factors may increase the risk of developing the condition:

• Genetics: People with MEN1 have a significantly higher risk of developing ZES and hypercalcemia. MEN1 is caused by mutations in the MEN1 gene and is inherited in an autosomal dominant pattern.
• Age: ZES is most commonly diagnosed in adults between 30 and 60 years old.
• Gender: Men are slightly more likely to develop ZES than women.
• Family history: A family history of MEN1 or other endocrine tumors increases the risk.

It’s important to note that most cases of ZES are sporadic (not inherited), but the presence of hypercalcemia often suggests an underlying genetic component like MEN1.

Diagnosis

Diagnosing Zollinger-Ellison Syndrome with hypercalcemia involves a combination of blood tests, imaging studies, and sometimes genetic testing. Early diagnosis is critical to prevent complications like severe ulcers or kidney damage.

Diagnostic Tests for ZES

• Gastrin blood test: Measures the level of gastrin in the blood. High gastrin levels (typically >1000 pg/mL) suggest ZES, though other conditions can also elevate gastrin.
• Stomach acid secretion test: Measures how much acid the stomach produces. In ZES, acid production is unusually high even after fasting.
• Secretin stimulation test: Secretin is a hormone that normally lowers gastrin levels. In ZES, gastrin levels rise after secretin is injected, confirming the diagnosis.

Diagnostic Tests for Hypercalcemia

• Calcium blood test: Measures total and ionized calcium levels. Hypercalcemia is typically defined as a total calcium level >10.5 mg/dL.
• Parathyroid hormone (PTH) test: High PTH levels suggest primary hyperparathyroidism, a common cause of hypercalcemia in ZES.
• Vitamin D test: Checks for vitamin D toxicity or deficiency, which can affect calcium levels.

Imaging and Localization

Once ZES is suspected, imaging tests are used to locate the gastrinomas:

• Endoscopic ultrasound (EUS): Uses sound waves to create images of the pancreas and duodenum.
• CT or MRI scans: Provide detailed images of the abdomen to identify tumors.
• Somatostatin receptor scintigraphy (Octreoscan): A nuclear scan that detects tumors expressing somatostatin receptors, common in gastrinomas.

Genetic Testing

If MEN1 is suspected (e.g., due to family history or hypercalcemia), genetic testing for the MEN1 gene mutation may be recommended. This can help guide treatment and screening for other potential tumors.

According to the Mayo Clinic, diagnosing ZES can be challenging because its symptoms mimic other digestive disorders. A thorough evaluation by a gastroenterologist or endocrinologist is essential.

Treatment Options

The treatment of Zollinger-Ellison Syndrome with hypercalcemia focuses on managing excess stomach acid, controlling calcium levels, and addressing the underlying tumors. A multidisciplinary approach involving gastroenterologists, endocrinologists, and surgeons is often required.

Medications

• Proton pump inhibitors (PPIs): These are the first-line treatment for reducing stomach acid. Examples include omeprazole (Prilosec), esomeprazole (Nexium), and pantoprazole (Protonix). High doses are often needed to control acid production in ZES.
• H2 blockers: Medications like famotidine (Pepcid) or ranitidine (Zantac) may be used if PPIs are not tolerated, though they are generally less effective for ZES.
• Calcimimetics: For hypercalcemia, medications like cinacalcet (Sensipar) can lower calcium levels by reducing PTH secretion.
• Bisphosphonates: Drugs like alendronate (Fosamax) or zoledronic acid (Reclast) may be used to strengthen bones and reduce calcium release from bones.
• Intravenous fluids and diuretics: In severe hypercalcemia, hospitalization may be required for IV fluids and medications like furosemide to help the kidneys excrete excess calcium.

Surgical and Procedural Treatments

• Tumor removal: If the gastrinomas are localized and haven’t spread, surgical removal may be curative. This is more likely in sporadic ZES cases than in MEN1-associated ZES, where tumors are often multiple.
• Parathyroid surgery: If hypercalcemia is due to overactive parathyroid glands (common in MEN1), surgical removal of the abnormal glands (parathyroidectomy) may be necessary.
• Embolization or ablation: For tumors that cannot be surgically removed, procedures like embolization (blocking blood flow to the tumor) or radiofrequency ablation (using heat to destroy the tumor) may be options.
• Liver-directed therapies: If gastrinomas have spread to the liver, treatments like chemoembolization or radioembolization may be used to target liver tumors.

Lifestyle and Dietary Changes

• Dietary modifications:
  • Avoid foods that trigger acid reflux, such as spicy foods, caffeine, alcohol, and fatty foods.
  • Eat smaller, more frequent meals to reduce stomach acid production.
  • Stay hydrated to help manage diarrhea and kidney stone risk.
  • Limit calcium-rich foods if hypercalcemia is severe, though this should be done under medical supervision to avoid deficiencies.
• Supplements:
  • Vitamin D and calcium supplements should only be taken if prescribed, as they can worsen hypercalcemia.
  • Magnesium supplements may be recommended if low magnesium levels are contributing to symptoms.
• Regular monitoring: Frequent blood tests to check gastrin, calcium, and PTH levels, as well as imaging studies to monitor tumor growth.

The National Cancer Institute (NCI) notes that while ZES cannot always be cured, treatments can effectively manage symptoms and improve quality of life.

Living with Zollinger-Ellison Syndrome with Hypercalcemia

Managing ZES with hypercalcemia requires ongoing medical care and lifestyle adjustments. Here are some practical tips for daily living:

Medication Management

• Take PPIs or other acid-reducing medications exactly as prescribed. Missing doses can lead to severe ulcer flare-ups.
• Keep a medication diary to track doses and any side effects.
• Work with your healthcare provider to adjust dosages as needed, especially if symptoms worsen.

Diet and Nutrition

• Work with a dietitian to create a meal plan that minimizes acid reflux and manages calcium levels.
• Avoid trigger foods and beverages, such as citrus fruits, tomatoes, chocolate, mint, and carbonated drinks.
• Increase fiber intake to help manage diarrhea, but introduce fiber gradually to avoid bloating.
• Stay hydrated by drinking plenty of water, especially if you experience frequent diarrhea.

Monitoring and Follow-Up

• Attend regular follow-up appointments with your gastroenterologist and endocrinologist.
• Undergo periodic blood tests to monitor gastrin, calcium, and PTH levels.
• Schedule regular imaging studies (e.g., CT scans, MRIs, or endoscopic ultrasounds) to check for tumor growth or spread.
• If you have MEN1, follow a screening protocol for other potential tumors, such as pituitary or adrenal tumors.

Lifestyle Adjustments

• Quit smoking, as smoking can worsen ulcer symptoms and increase the risk of complications.
• Limit alcohol intake, as it can irritate the stomach lining and interfere with medications.
• Manage stress through techniques like meditation, yoga, or counseling, as stress can exacerbate digestive symptoms.
• Stay physically active to support bone health and overall well-being, but avoid high-impact activities if you have bone pain or osteoporosis.

Support and Education

• Join support groups for people with ZES, MEN1, or rare digestive disorders. Organizations like the National Organization for Rare Disorders (NORD) can provide resources.
• Educate family members about the condition, especially if there is a genetic component like MEN1.
• Carry a medical alert card or wear a bracelet that lists your condition, medications, and emergency contacts.

Living with ZES and hypercalcemia can be challenging, but with the right treatment plan and support, many people lead active, fulfilling lives.

Prevention

Since most cases of Zollinger-Ellison Syndrome are sporadic (not inherited), there is no sure way to prevent the condition. However, if you have a family history of MEN1 or other endocrine tumors, the following steps may help reduce risks or lead to early detection:

Genetic Counseling and Testing

• If you have a family history of MEN1, consider genetic counseling and testing to determine if you carry the MEN1 gene mutation.
• If you test positive for MEN1, work with your healthcare provider to develop a surveillance plan for early detection of tumors, including gastrinomas and parathyroid tumors.

Regular Screenings

• People with MEN1 should undergo regular screenings, including:
  • Blood tests for gastrin, calcium, PTH, and other hormones.
  • Imaging studies like CT scans, MRIs, or endoscopic ultrasounds.
• Screenings typically begin in early adulthood or even childhood, depending on family history.

Lifestyle Choices

• Avoid smoking and limit alcohol consumption, as these can worsen digestive symptoms and increase cancer risks.
• Maintain a healthy diet rich in fruits, vegetables, and whole grains to support overall health.
• Stay physically active to reduce the risk of obesity and other chronic conditions that may complicate ZES management.

Early detection and treatment of gastrinomas and hypercalcemia can significantly improve outcomes and reduce the risk of complications.

Complications

If left untreated, Zollinger-Ellison Syndrome with hypercalcemia can lead to serious, even life-threatening complications. Some of the most common complications include:

Complications from ZES

• Severe peptic ulcers: Excess stomach acid can lead to deep, painful ulcers in the stomach, duodenum, or even the esophagus. These ulcers may bleed or perforate (create a hole in the digestive tract), requiring emergency surgery.
• Gastrointestinal bleeding: Chronic bleeding from ulcers can lead to anemia (low red blood cell count), causing fatigue, weakness, and shortness of breath.
• Malabsorption and malnutrition: Chronic diarrhea and damage to the digestive tract can impair nutrient absorption, leading to weight loss, vitamin deficiencies, and muscle wasting.
• Tumor metastasis: Gastrinomas can spread (metastasize) to nearby lymph nodes, the liver, or other organs. According to the American Society of Clinical Oncology (ASCO), about 50-60% of gastrinomas are malignant (cancerous) and may spread over time.

Complications from Hypercalcemia

• Kidney stones: High calcium levels can cause calcium deposits to form in the kidneys, leading to painful kidney stones. Recurrent kidney stones can damage the kidneys over time.
• Kidney failure: Severe or prolonged hypercalcemia can impair kidney function, potentially leading to chronic kidney disease or acute kidney failure.
• Osteoporosis: Excess calcium in the blood often comes from bones, weakening them and increasing the risk of fractures.
• Cardiac complications: Hypercalcemia can cause irregular heartbeats (arrhythmias), high blood pressure, or even heart attack in severe cases.
• Neurological issues: High calcium levels can affect the brain, leading to confusion, memory problems, depression, or in extreme cases, coma.

Complications from MEN1

If ZES is part of MEN1, additional complications may arise from other tumors, such as:

• Pituitary tumors: Can cause hormonal imbalances, vision problems, or headaches.
• Adrenal tumors: May lead to excess hormone production, affecting blood pressure, metabolism, or electrolyte balance.

Early diagnosis and treatment are key to preventing these complications. Regular monitoring and adherence to treatment plans can significantly reduce risks.

When to Seek Emergency Care

Emergency Symptoms Related to ZES

• Severe abdominal pain: Sudden, sharp pain that doesn’t improve with medication could indicate a perforated ulcer, which is a medical emergency.
• Vomiting blood or black, tarry stools: These are signs of significant gastrointestinal bleeding, which can lead to shock if untreated.
• Signs of shock: Rapid heartbeat, low blood pressure, cold or clammy skin, confusion, or loss of consciousness. Shock can occur due to severe bleeding or infection.
• Severe diarrhea with dehydration: Symptoms of dehydration include extreme thirst, dry mouth, little or no urination, dizziness, or fainting.

Emergency Symptoms Related to Hypercalcemia

• Severe confusion or altered mental state: High calcium levels can cause delirium, hallucinations, or loss of consciousness.
• Irregular heartbeat or chest pain: Hypercalcemia can lead to dangerous heart rhythms or even heart attack.
• Severe muscle weakness or difficulty moving: Extremely high calcium levels can impair muscle function, making it hard to walk or perform daily activities.
• Intense bone pain or fractures: Especially if occurring without significant trauma, as this may indicate severe bone weakening.
• Severe nausea, vomiting, or inability to keep fluids down: This can worsen dehydration and electrolyte imbalances.

When in Doubt, Seek Help

If you or someone you care for experiences symptoms that are severe, sudden, or worsening, do not wait—go to the nearest emergency room or call emergency services. Prompt treatment can prevent serious complications and improve outcomes.

For non-emergency concerns, contact your healthcare provider if:

• Symptoms like diarrhea, abdominal pain, or heartburn persist despite treatment.
• You notice new or worsening symptoms, such as unexplained weight loss or fatigue.
• You have difficulty managing medications or side effects.

Always err on the side of caution when dealing with ZES and hypercalcemia, as delays in treatment can have serious consequences.

References and Further Reading

For more information about Zollinger-Ellison Syndrome and hypercalcemia, consult these reputable sources:

• Mayo Clinic: Zollinger-Ellison Syndrome
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Zollinger-Ellison Syndrome
• National Cancer Institute (NCI): Rare Tumors
• Hormone Health Network: Hypercalcemia
• National Organization for Rare Disorders (NORD)